(Q33915947)

30 July 2017

1 reference

title

Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation (English)

1 reference

30 July 2017

1 reference

1 reference

T Kawada

1

1 reference

30 July 2017

H Kitagawa

2

1 reference

30 July 2017

M Hoson

3

1 reference

30 July 2017

Y Okada

4

1 reference

30 July 2017

J Shiomura

5

1 reference

30 July 2017

publication date

1 April 2000

1 reference

Hematology / Oncology Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

14

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

445-57, x

1 reference

Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Thrombin and antithrombotics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Predictors of intracranial hemorrhage during neonatal extracorporeal membrane oxygenation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Response to heparinization in adults and children undergoing cardiac operations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Direct thrombin inhibitors in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Extracorporeal membrane oxygenation: preliminary results in patients with postcardiotomy cardiogenic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Experience with emergency cardiac surgery following institution of percutaneous cardiopulmonary support

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Heparin free long-term extracorporeal circulation using bioactive surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Percutaneous initiation of cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Percutaneous cardiopulmonary bypass: application and indication for use.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Improved patient survival after cardiac arrest using a cardiopulmonary support system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Argatroban as a potential anticoagulant in cardiopulmonary bypass-studies in a dog model

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Extracorporeal membrane oxygenation (ECMO): prolonged bedside cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Risk and benefit of low systemic heparinization during open heart operations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Extracorporeal membrane oxygenation for nonneonatal pulmonary and multiple-organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

Adequate Anticoagulation During Cardiopulmonary Bypass Determined by Activated Clotting Time and the Appearance of Fibrin Monomer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970144-1

7 January 2021

10.1016/S0889-8588(05)70144-1

Identifiers

DOI

1 reference

30 July 2017

1 reference